Andrew L. Pecora is Director at NeoStem, Inc. (NBS). They have made 8 open-market trades across 3 companies since 2011, most recently 2016-06-22.
CIK 0001510184
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $710K since 2011, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TLOG | BUY | 2015-07-10 | 2015-07-14 | $2.68 | $134K | -81.5% | +0.5% | +0.5% |
| TLOG | BUY | 2015-07-09 | 2015-07-13 | $2.40 | $120K | -81.5% | +0.5% | +0.5% |
| NBS | BUY | 2014-11-24 | 2014-11-25 | $4.01 | $50K | N/A | N/A | N/A |
| TLOG | BUY | 2014-11-17 | 2014-11-19 | $4.53 | $91K | -81.5% | +0.5% | +0.5% |
| TLOG | BUY | 2013-12-17 | 2013-12-19 | $7.00 | $186K | -81.5% | +0.5% | +0.5% |
| CGIX | SELL | 2013-11-18 | 2013-11-20 | $14.27 | $713K | -33.9% | +0.6% | +0.6% |
| NBS | BUY | 2011-12-14 | 2011-12-15 | $0.59 | $30K | N/A | N/A | N/A |
| NBS | BUY | 2011-03-03 | 2011-03-04 | $1.28 | $100K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.